Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
Clinical trial NCT00134251 · COMPLETED
Trial details
- NCT number
- NCT00134251
- Sponsor
- Solvay Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.